Grifols board member says response to market regulator imminent
2024-01-19
并购
The logo of the Spanish pharmaceuticals company Grifols is pictured on theirs facilities in Parets del Valles, north of Barcelona, Spain, January 9, 2024. REUTERS/Albert Gea/File Photo Acquire Licensing Rights, opens new tab
Reporting by Joan Faus, additional reporting by Jesús Aguado, Tiago Brandao and Matteo Allievi, editing by Inti Landauro, David Latona and Barbara Lewis
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Preview
来源: Reuters
Thomson Reuters
Joan is a Barcelona-based correspondent reporting on politics, economics and social issues, such as migration and the car industry’s green transition, and also conducting investigative pieces. With over 15 years of experience, Joan previously worked as Washington correspondent for Spain’s leading newspaper EL PAÍS, closely covering the Obama and Trump administrations, electoral campaigns and major news; at Spanish newspapers Ara and Público in Madrid, and at EFE news agency in Buenos Aires and Barcelona. He is a journalism graduate from Barcelona’s Autonomous University, including an exchange program in Amsterdam and New York, and holds a business executive degree from IESE Business School
Preview
来源: Reuters
Preview
来源: Reuters
Preview
来源: Reuters
Preview
来源: Reuters
Preview
来源: Reuters
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
-靶点
-药物
-来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。